URGN
UroGen Pharma Ltd. - Ordinary Shares (URGN)
$65
About UroGen Pharma Ltd. - Ordinary Shares (URGN)
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Details
Daily high
$15.61
Daily low
$14.32
Price at open
$15.10
52 Week High
$18.15
52 Week Low
$3.42
Market cap
685.6M
Dividend yield
0.00%
Volume
3.4M
Avg. volume
6.1M
P/E ratio
-4.68
UroGen Pharma Ltd. - Ordinary Shares News
Details
Daily high
$15.61
Daily low
$14.32
Price at open
$15.10
52 Week High
$18.15
52 Week Low
$3.42
Market cap
685.6M
Dividend yield
0.00%
Volume
3.4M
Avg. volume
6.1M
P/E ratio
-4.68